Status:
COMPLETED
Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborating Sponsors:
The People's Hospital of Liaoning Province
The First Hospital of Jilin University
Conditions:
Asymptomatic Intracranial Atherosclerotic Stenosis Patients
Eligibility:
All Genders
30-80 years
Brief Summary
This prospective cohort study aims to establish a large-scale cohort for primary stroke prevention in asymptomatic intracranial atherosclerosis (ICAS). Objectives include: characterizing risk factor a...
Eligibility Criteria
Inclusion
- Intracranial arterial stenosis confirmed by transcranial Doppler (TCD), clinically suspected to be of atherosclerotic origin
- No history of stroke or transient ischemic attack (TIA)
- Adequate temporal bone acoustic window penetrability
Exclusion
- Clinically diagnosed non-atherosclerotic etiology-related intracranial arterial stenosis
- Poor temporal bone acoustic window penetrability
- Loss to follow-up
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
3849 Patients enrolled
Trial Details
Trial ID
NCT07156344
Start Date
January 1 2019
End Date
April 30 2025
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053